HARVARD BIOSCIENCE INC (HBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 50M 100M 150M Q3 '21: 116.8M Q4 '21: 118.9M Q1 '22: 120.7M Q2 '22: 120.7M Q3 '22: 118M Q4 '22: 113.3M Q1 '23: 114.5M Q2 '23: 114.1M Q3 '23: 112.5M Q4 '23: 112.2M Q1 '24: 106.8M Q2 '24: 101.1M Q3 '24: 97.7M Q4 '24: 94.1M Q1 '25: 91.4M Q2 '25: 88.8M Q3 '25: 87.4M Q4 '25: 86.5M Q1 '26: 85.5M Q2 '26: 87.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 25M 50M 75M Q3 '21: 65.8M Q4 '21: 67.7M Q1 '22: 68.4M Q2 '22: 68.7M Q3 '22: 64.5M Q4 '22: 60.8M Q1 '23: 63M Q2 '23: 63M Q3 '23: 65.6M Q4 '23: 66.1M Q1 '24: 62.5M Q2 '24: 59M Q3 '24: 57.1M Q4 '24: 54.8M Q1 '25: 52.2M Q2 '25: 50.5M Q3 '25: 49.7M Q4 '25: 49.9M Q1 '26: 50M Q2 '26: 51.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-60M -40M -20M 0 20M 40M 60M Q3 '20: -902K Q4 '21: 2.1M Q1 '22: -4.4M Q2 '22: -467K Q3 '22: -4.8M Q4 '22: -6.9M Q1 '23: 1.5M Q2 '23: -1.7M Q3 '23: 1.2M Q4 '23: 1.9M Q1 '24: -2.1M Q2 '24: -5M Q3 '24: -5.9M Q4 '24: -6.2M Q1 '25: -53.6M Q2 '25: -52.4M Q3 '25: -50.3M Q4 '25: -48.6M Q1 '26: -86K Q2 '26: -245K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-60M -40M -20M 0 20M 40M 60M Q3 '21: -1.9M Q4 '21: -288K Q1 '22: -6.5M Q2 '22: -3.7M Q3 '22: -6.9M Q4 '22: -9.5M Q1 '23: -2M Q2 '23: -5.4M Q3 '23: -3.3M Q4 '23: -3.4M Q1 '24: -8.7M Q2 '24: -10.7M Q3 '24: -14.2M Q4 '24: -12.4M Q1 '25: -58.1M Q2 '25: -57.4M Q3 '25: -53.8M Q4 '25: -56.7M Q1 '26: -9.8M Q2 '26: -10.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 20M 40M 60M Q3 '21: 51M Q4 '21: 51.3M Q1 '22: 52.3M Q2 '22: 52M Q3 '22: 53.4M Q4 '22: 52.5M Q1 '23: 51.5M Q2 '23: 51.1M Q3 '23: 46.9M Q4 '23: 46.2M Q1 '24: 44.3M Q2 '24: 42.1M Q3 '24: 40.7M Q4 '24: 39.4M Q1 '25: 39.2M Q2 '25: 38.3M Q3 '25: 37.6M Q4 '25: 36.6M Q1 '26: 35.6M Q2 '26: 36.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-5M 0 5M 10M 15M Q3 '20: 9.1M Q4 '20: 9.3M Q1 '21: 7.5M Q2 '21: 5.9M Q3 '21: 3.6M Q4 '21: 1.3M Q1 '22: -1.8M Q2 '22: -2.7M Q3 '22: -1.4M Q4 '23: 14M Q1 '24: 13.6M Q2 '24: 9.2M Q3 '24: 4M Q4 '24: 1.4M Q1 '25: 3M Q2 '25: 6.6M Q3 '25: 8.6M Q4 '25: 6.7M Q1 '26: 3.1M Q2 '26: 651K Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-5M 0 5M 10M 15M Q3 '20: 7.5M Q4 '20: 8.2M Q1 '21: 6.4M Q2 '21: 4.9M Q3 '21: 2.7M Q4 '21: 67K Q1 '22: -3.3M Q2 '22: -4.5M Q3 '22: -3.1M Q4 '23: 12.2M Q1 '24: 11.4M Q2 '24: 6.7M Q3 '24: 845K Q4 '24: -1.2M Q1 '25: 511K Q2 '25: 4.8M Q3 '25: 7.4M Q4 '25: 5.5M Q1 '26: 1.9M Q2 '26: -1.1M Q4 '20 Q3 '21 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '20: 38.3M Q2 '20: 38.5K Q3 '20: 38.9K Q1 '21: 39.8M Q2 '21: 40.2M Q3 '21: 40.8M Q1 '22: 41.2M Q2 '22: 42.6M Q3 '22: 41.6M Q1 '23: 42.8M Q2 '23: 42.4M Q3 '23: 42.7M Q1 '24: 43.4M Q2 '24: 43.5M Q3 '24: 43.6M Q1 '25: 4.4M Q2 '25: 4.4M Q3 '25: 44.6M Q1 '26: 4.5M Q2 '26: 4.5M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q3 '19: -0.06 Q4 '19: -0.12 Q1 '20: -0.18 Q3 '21: -0.04 Q4 '21: -0.01 Q1 '22: -0.16 Q2 '22: -0.09 Q3 '22: -0.17 Q4 '22: -0.23 Q1 '23: -0.05 Q2 '23: -0.13 Q3 '23: -0.08 Q4 '23: -0.08 Q1 '24: -0.20 Q2 '24: -0.25 Q3 '24: -0.33 Q4 '24: -0.28 Q1 '25: -11.59 Q2 '25: -12.04 Q3 '25: -11.96 Q4 '19 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.